CLINICAL_TRIALS
research
· 2019-01-17
Clinical Trial Update: Preeclampsia: A Marker for Future Cardiovascular Risk in Women [NA]
Summary
A clinical trial evaluating whether preeclampsia serves as a marker for future cardiovascular risk in women has been suspended.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Brigham and Women's Hospital | Conditions: Preeclampsia, Pregnancy Induced Hypertension | NA | Status: SUSPENDED